Research & Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, IG3 8XJ, UK.
Division of Psychiatry, University College London, London, W1T 7NF, UK.
BMC Psychiatry. 2022 Mar 15;22(1):185. doi: 10.1186/s12888-022-03822-5.
Antipsychotic medication can reduce psychotic symptoms and risk of relapse in people with schizophrenia and related disorders, but it is not always effective and adverse effects can be significant. We know little of patients' views about continuing or discontinuing antipsychotic treatment.
To explore the views of people with schizophrenia and other psychotic disorders about continuing their antipsychotic medication or attempting to reduce or discontinue this medication with clinical support.
We collected quantitative and qualitative data by conducting semi-structured interviews in London, UK. Factors predicting a desire to discontinue medication were explored. Content analysis of qualitative data was undertaken.
We interviewed 269 participants. 33% (95% CI, 27 to 39%) were content with taking long-term antipsychotic medication. Others reported they took it reluctantly (19%), accepted it on a temporary basis (24%) or actively disliked it (18%). 31% (95% CI, 25 to 37%) said they would like to try to stop medication with professional support, and 45% (95% CI, 39 to 51%) wanted the opportunity to reduce medication. People who wanted to discontinue had more negative attitudes towards the medication but were otherwise similar to other participants. Wanting to stop or reduce medication was motivated mainly by adverse effects and health concerns. Professional support was identified as potentially helpful to achieve reduction.
This large study reveals that patients are commonly unhappy about the idea of taking antipsychotics on a continuing or life-long basis. Professional support for people who want to try to reduce or stop medication is valued.
抗精神病药物可降低精神分裂症和相关障碍患者的精神病症状和复发风险,但并非总是有效,且可能产生显著的不良反应。我们对患者继续或停止使用抗精神病药物的看法知之甚少。
探究精神分裂症和其他精神病患者在临床支持下继续或尝试减少或停止使用抗精神病药物的看法。
我们在英国伦敦进行了半结构化访谈,收集了定量和定性数据。探讨了预测停药意愿的因素。对定性数据进行了内容分析。
我们共访谈了 269 名参与者。33%(95%置信区间,27 至 39%)的人愿意长期服用抗精神病药物。其他人则表示他们是不情愿地(19%)、暂时接受(24%)或积极反对(18%)服用该药。31%(95%置信区间,25 至 37%)的人表示,他们希望在专业支持下尝试停药,45%(95%置信区间,39 至 51%)的人希望有机会减少药物剂量。希望停药或减药的人对药物的态度更为消极,但其他方面与其他参与者相似。希望停药或减药主要是由于药物的不良反应和健康问题。人们认为专业支持可能有助于减少药物剂量。
这项大规模研究表明,患者通常对继续或终身服用抗精神病药物的想法感到不满。人们希望获得专业支持来尝试减少或停止用药,这一点很有价值。